Drug intelligence / Profile preview

PIEX 3

Development stage
Unknown
Lead developer
Becanex
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Inhalation, Oral, Rectal, Topical
01

Overview

PIEX 3 is a plant-identical cannabis raw extract (Rohextrakt) developed by Becanex. It is standardized to contain 62% cannabidiol (CBD) and less than 5% tetrahydrocannabinol (THC), derived consistently from the God Bud cannabis strain (an Indica-dominant hybrid). The extraction process preserves the natural cannabinoid and terpene fingerprint of the source flower to leverage the entourage effect. PIEX 3 is designed for pharmacy compounding into various medicinal forms, including inhalation solutions for vaporization, oral oils, capsules, suppositories, and topical preparations, and is available for medical prescription in Germany.

Brand names
Becanex PIEX 3PIEX 3PIEX3PIEX-3
Other names
62% CBD concentrateBecanex PIEX 3 62% CBD RohextraktGod Bud strain extract

Beyond the preview

Go deeper on PIEX 3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PIEX 3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call